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Beta-sitosterol (BS) and pteropodine (PT) are constituents of various plants with pharmacological activities potentially useful to
man. The chemicals themselves possess biomedical properties related to the modulation of the immune and the nervous systems,
as well as to the inﬂammatory process. Therefore, safety evaluation of the compounds is necessary in regard to their probable
beneﬁcial use in human health. The present study evaluates their genotoxic and cytotoxic potential by determining the capacity of
the compounds to induce sister chromatid exchanges (SCE), or to alter cellular proliferation kinetics (CPK) and the mitotic index
(MI) in mouse bone marrow cells. Besides, it also determines their capacity to increase the rate of micronucleated polychromatic
erythrocytes (MNPE) in peripheral mouse blood, and the relationship polychromatic erythrocytes/normochromatic erythrocytes
(PE/NE) as an index of cytotoxicity. For the ﬁrst assay, four doses of each compound were tested: 200, 400, 600, and 1000mg/kg in
case of BS, and 100, 200, 300, and 600mg/kg for PT. The results in regard to both agents showed no SCE increase induced by any
of the tested doses, as well as no alteration in the CPK, or in the MI. With respect to the second assay, the results obtained with the
two agents were also negative for both the MNPE and the PE/NE index along the daily evaluation made for four days. In the present
study, the highest tested dose corresponded to 80% of the LD50 obtained for BS and to 78% in the case of PT. The results obtained
establish that the studied agents have neither genotoxic nor cytotoxic eﬀect on the model used, and therefore they encourage studies
on their pharmacological properties.
INTRODUCTION
The isolation and chemical characterization of plant-
derived compounds with therapeutic or other beneﬁcial
health properties are increasing, in many cases as a con-
sequence of primary information obtained through the
use of plant extractsin traditional medicine. However, the
possibleuseofthesecompoundsforhumanwell-beingre-
quires solid and lengthy research which includes a num-
ber of basic and applied phases; one of the determinations
in this complex evaluation concerns the toxic potential of
the studied agent.
Beta-sitosterol (BS) (Figure 1) is one of the most
prevalent vegetable-derived phytosterols in the diet. It is
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structurally related to cholesterol, but since it is slowly ab-
sorbed in the intestinal tract, it may interfere with the
cholesterol absorption preventing its rise in serum. BS
also appears to modulate the immune function, inﬂam-
mation, and the pain levels by controlling the produc-
tion of inﬂammatory cytokines [1, 2]. This last eﬀect
may help to control allergies and reduce prostate enlarge-
ment [3, 4]. The compound can aﬀect the structure of cell
membranesandaltersthesignalingpathwaysthatregulate
tumor growth and apoptosis [5]. Moreover, BS has shown
a decrease in proliferative changes and tumor yields when
addedtodietsofmiceandratstreatedwithcoloncarcino-
gens [6, 7]. The compound is found in numerous plants,
including rice, wheat, corn, nut, peanut, and particularly
in the Peruvian borne Rubiaceae plant cat’s claw (Uncaria
tomentosa)[ 8, 9], where it seems to be involved in the cu-
rative properties suggested for the vegetable, such as anti-
inﬂammatory and antiviral activities, enhancer of the im-
mune system, and inhibitor of arthritis, ulcer, and cancer
[10, 11, 12, 13].
Pteropodine or uncarine C (PT) (Figure 1)i sa
chemical speciﬁcally isolated from cat’s claw. It is a
heteroyohimbine-type oxindole whose biological proper-
ties have been studied less than those of BS. However,2005:3 (2005) Absence of Genotoxicity by Beta-Sitosterol and Pteropodine 243
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Figure 1. Stereochemical structure of beta-sitosterol (a) and
pteropodine (b).
it is probably the most immunologically active of the
six oxindole alkaloids identiﬁed in the plant, show-
ing a pronounced enhancement of phagocytosis, as well
as a modulatory eﬀect on the muscarinic M1 and 5-
hydroxytryptaminereceptors[14,15,16].Thesedatasug-
gest that it may act in synergism with other components
of the plant to induce its biomedical actions.
The compounds selected for this study are con-
stituents of cat’s claw, a plant claimed to have therapeu-
tic properties for various diseases, mainly related to in-
ﬂammatory, immunological, and cancer processes; with
respect to the last illness, aqueous extracts of the plant
haveshownsigniﬁcantantiproliferativeeﬀectinleukemia,
lymphoma, and breast human cancer cell lines [17, 18];
results that point to the need for in vivo assays of the ex-
tracts and their constituents. Therefore, the evaluation of
the BS and PT toxicity in a mammalian organism seems
mandatory in order to continue with pharmacological
and anthropogenic research that may be applicable to hu-
mans. In regard to genotoxic potential, insuﬃcient in-
formation on the compounds have been reported; it is
known that Uncaria tomentosa extracts have no metal-
lic capacity, and a negative result was reported in a study
that measured the micronuclei produced by BS, although
a single low dose was used in the assay [19, 20]. In re-
gard to PT no information on the matter have been re-
ported.
In view of the knowledge that the determination of
damage to genetic material is a useful biomarker of xeno-
biotic exposure, as well as the fact that our laboratory
is evaluating the anthropogenic potential of both com-
pounds in mouse, we found it pertinent to determine the
genotoxicity of the compounds. In this report we show
that the two substances are not capable of increasing the
rate of sister chromatid exchanges (SCE) and micronu-
clei (MN) in mouse, nor of inducing toxicity in the same
model.
MATERIALS AND METHODS
Chemicalsandanimals
Pteropodine (99% pure) and beta-sitosterol (97%
pure) were obtained from Proﬁqua Chemicals (Mexico
City); 5-bromodeoxyuridine (BrdU), doxorubicin, and
colchicine were purchased from Sigma Chemicals (St
Louis, Mo, USA). The Giemsa stain was obtained from
Merck (Mexico City), and sodium citrate, sodium chlo-
ride, potassium phosphate, and sodium phosphate from
B a k e rS .A .( M e x i c oC i t y ) .
Eight-week-old male mice (NIH) with 25g of weight
were obtained from the National Institute of Hygiene;
they were kept in metallic cages at a mean temperature
of 23◦C and at a 12hours dark-light cycle, and permitted
to freely consume food (Purina) and water.
Genotoxicityprotocols
Lethaldose50
The ﬁrst step for the genotoxic evaluation was the de-
termination of the acute toxicity of both compounds. For
this purpose we applied the method of Lorke, which uses
3 animals and 3 doses in a ﬁrst step, and 1 animal and
four doses in a second step [21]. Mortality among mice
was observed for as long as 7 days; the LD50 was obtained
as the geometric mean between the minimal lethal dose
and the maximal sublethal dose. The test showed an LD50
of 1250mg/kg for BS and of 771mg/kg for PT.
Sister-chromatidexchanges,cellularproliferationkinetics,
andmitoticindex
Six experimental groups per chemical (ﬁve mice per
group) were used for these determinations. The com-
pounds were intraperitoneally (IP) administered. In the
case of BS the groups were as follows: a negative con-
trol group of animals administered with mineral oil
(0.4mL/mouse), a positive control group treated with
10mg/kg of doxorubicin, and four groups administered
with200,400,600,and1000mg/kgofthetestedchemical.
With respect to PT, this was dissolved in distilled water
(in a water bath at 37◦ C for a few minutes); thus, water
was administered to the animals of the negative control
group (0.4mL/mouse). We also included a positive con-
trol group (doxorubicin, 10mg/kg), as well as four more
groups treated with 100, 200, 300, and 600mg/kg of the
tested agent.244 R. Paniagua-P´ erez et al 2005:3 (2005)
Table 1. Sister chromatid exchanges (SCE), average generation time (AGT), and mitotic index (MI) induced by beta-sitosterol (BS)
and pteropodine (PT) in mouse bone marrow cells. MO = mineral oil (0.4mL added to each mouse). DW = distilled water (0.4mL
addedtoeachmouse).DR = doxorubicin.M1,M2,M3 = cells in ﬁrst,second,andthirdcellulardivision.AGT = 21(M1+2M2+3M3)
(100).
Agent Dose SCE M1 M2 M3 AGT MI
mg/kg X ±SD %%% X ±SD X ±SD
MO — 1.88 ±0.12 38 48 14 12.15 ±0.23 5.73 ±0.34
BS 200 2.12 ±0.28 32 53 15 12.14 ±0.17 5.66 ±0.29
BS 400 1.54 ±0.21 36 50 14 12.45 ±0.12 5.70 ±0.18
BS 600 1.34 ±0.24 34 55 11 12.55 ±0.10 5.58 ±0.33
BS 1000 1.0 ±0.34 33 52 15 12.35 ±0.18 6.03 ±0.22
DR 10 ∗16.83 ±0.42 33 58 9 12.37 ±0.31 6.43 ±0.41
DW — 2.51 ±0.12 34 51 15 12.45 ±0.23 5.94 ±0.19
PT 100 1.15 ±0.16 35 51 14 12.36 ±0.14 5.97 ±0.26
PT 200 2.03 ±0.27 37 50 13 12.46 ±0.21 5.80 ±0.38
PT 300 1.08 ±0.57 34 51 15 12.25 ±0.33 6.70 ±0.18
PT 600 1.44 ±0.22 34 49 17 12.63 ±0.16 7.13 ±0.17
DR 10 ∗14.06 ±0.68 39 50 11 12.47 ±0.26 6.16 ±0.68
∗Statistically signiﬁcant diﬀerence with respect to the result obtained in the negative control group. ANOVA and Student t tests, P ≤ .05.
To begin the procedure, a BrdU tablet of 50mg was
partially coated with paraﬃn and subcutaneously im-
planted to each animal [22]; 1hour afterwards the chem-
icals were injected to mice. Twenty-one hours after the
tablet implantation, 5mg/kg of colchicine was IP injected
to mice and permitted to act for 3hours. Then, the fe-
murs of each mouse were dissected and the bone mar-
row obtained in a solution of KCl (0.075M) at 37◦Ca f t e r
whichitwasincubatedfor30minutesatthesametemper-
ature. The cell suspension was centrifuged for 10minutes
at 1500rpm, the supernatant was discarded, and the cells
were ﬁxed in a solution of methanol-acetic acid (3 : 1).
This ﬁxation process was repeated at least twice. To carry
outthestainingprocess,twodropsofeachcellsuspension
were deposited onto ethanol-cleaned slides and stained
with the Hoechst-Giemsa method to diﬀerentiate the sis-
ter chromatids [22, 23].
Cytogenetic analysis per mouse was made as follows:
(a) the rate of SCE was determined in 60-second division
metaphases, (b) the cellular proliferation kinetics (CPK)
wasdeterminedin100metaphases,identifyingthecellsin
ﬁrst (M1), second (M2), and third (M3) cellular division.
With these data, the average generation time (AGT) was
obtained using the formula AGT = 21/(M1+2M2+3M3)
(100), and (c) the mitotic index (MI) was determined in
1000 cells. Statistical analysis of the obtained data was
made with ANOVA test followed by the Student t test.
Micronucleatedpolychromaticerythrocytes(MNPE)
Six groups with 5 individuals each per chemical were
organized for this assay. The compounds were IP inocu-
lated. The groups for BS were a negative control group
treated with mineral oil, a positive control group ad-
ministered with 10mg/kg of doxorubicin, and four more
groups treated with 200, 400, 600, and 1000mg/kg of BS.
InthecaseofPT,fourgroupswereadministeredwith100,
200, 300, and 600mg/kg of the chemical. The results ob-
tained in these animals were compared to the obtained
results in the negative control group (distilled water) and
the positive control group (10mg/kg doxorubicin).
Initially, we obtained two drops of blood from the
tail of each mouse and smeared them on ethanol-
cleaned slides; then, the cells were ﬁxed in methanol for
10minutes and stained for 15minutes with Giemsa solu-
tion made in PBS (pH = 6.8) [24]. Afterward, the tested
chemicals were administered to mice and their blood was
obtained at 24, 48, 72, and 96hours and then it was
stained as indicated earlier.
Todeterminethegenotoxicpotentialofthechemicals,
the rate of MNPE in 1000 polychromatic erythrocytes
(PE) per mouse was quantiﬁed; to evaluate the probable
cytotoxic damage, the number of PE and of normochro-
matic erythrocytes (NE) in 1000 cells per mouse was de-
termined. The statistical signiﬁcance of the obtained data
was determined with the ANOVA and the Student t tests.
RESULTS
Beta-sitosterol
The acute toxicity assay made to this compound
showed a lower lethal potential (38%) than the obtained
for PT. The results for SCE, AGT, and the MI are indi-
cated in Table 1. With respect to the rate of SCE, we found
a similar level (with the four tested doses) to the one ob-
servedinthenegativecontrolgroup;however,thepositive
control agent (doxorubicin) revealed an increase of about
six times that level. The same table shows a homogeneous
AGT value of the four tested doses of BS, with a variabil-
ity of no more than 30minutes among them; these values
are very close to those obtained in the controls. A similar
eﬀect, that is, no modiﬁcation by BS was also determined2005:3 (2005) Absence of Genotoxicity by Beta-Sitosterol and Pteropodine 245
Table 2. Frequency of micronucleated polychromatic erythrocytes (MNPE) induced by beta-sitosterol (BS) and pteropodine (PT) in
mouse blood cells. MO = mineral oil (0.4mL added to each mouse). DW = distilled water (0.4mL added to each mouse). DR =
doxorubicin.
Agent Dose MNPE X ±SD
mg/kg 24h 48h 72h 96h
MO — 1.6 ±0.26 2.05 ±0.18 1.74 ±0.21 1.1 ±0.32
BS 200 1.13 ±0.15 0.83 ±0.31 0.83 ±0.15 1.0 ±0.42
BS 400 1.33 ±0.21 1.03 ±0.33 1.0 ±0.43 1.33 ±0.32
BS 600 1.40 ±0.19 1.53 ±0.18 1.20 ±0.23 1.0 ±0.17
BS 1000 1.7 ±0.17 1.3 ±0.24 1.4 ±0.24 1.0 ±0.26
DR 10 ∗18.26 ±0.26 ∗19.3 ±0.29 ∗25.4 ±0.31 ∗20.5 ±0.22
DW — 1.4 ±0.31 1.35 ±0.46 1.3 ±0.33 1.45 ±0.17
PT 100 1.3 ±0.44 1.4 ±0.31 1.5 ±0.25 1.5 ±0.27
PT 200 1.4 ±0.26 1.5 ±0.16 1.6 ±0.13 1.61 ±0.51
PT 300 1.4 ±0.39 1.55 ±0.51 1.7 ±0.41 1.71 ±0.28
PT 600 1.5 ±0.19 1.64 ±0.31 1.6 ±0.32 1.65 ±0.36
DR 10 ∗19.15 ±0.3 ∗21.72 ±0.17 ∗24.3 ±0.34 ∗22.82 ±0.17
∗Statistically signiﬁcant diﬀerence with respect to the result obtained in the negative control group. ANOVA and Student t tests, P ≤ .05.
withrespecttothecelldivisionrate,asshownbythesimi-
lar MI values observed in BS-treated mice and the control
animals.
The rate of micronuclei induced by this chemical is
shown in Table 2. The mean number of MNPE/1000
cells determined in the negative control group along the
96hours was 1.62; the mean values observed in the BS-
treated groups were 0.94, 1.17, 1.28, and 1.35 correspond-
ing to the doses of 200, 400, 600, and 1000mg/kg, re-
spectively, clearly showing an absence of genotoxicity. On
the contrary, the MNPE mean determined for doxoru-
bicin was high as expected, particularly at 72hours (25.4
MNPE/1000 cells). The innocuous capacity of BS for mi-
cronuclei induction paralleled the absence of its cytotoxic
potential shown by the frequency of polychromatic ery-
throcytes (Table 3). The table shows PE daily values sim-
ilar to those determined in the negative control animals
and contrary to those in doxorubicin-treated mice, in
whichasigniﬁcantPEratedecrease(74%at72hours)was
found in comparison with the mean of the other groups.
Pteropodine
The LD50 of this compound was higher than the de-
termined for BS. However, the results obtained for SCE,
AGT, and mitotic index (Table 1) are similar to the de-
scribed ones for the previous chemical. No increase in
any of the four parameters was found with respect to
the negative control value, but as expected, a signiﬁcant
SCE rate was determined with doxorubicin which was 5.6
times higher than the control value. The AGT and the mi-
totic index also showed no modiﬁcation in relation to the
control level.
WithrespecttotherateofMNPE,theresultsindicated
in Table 2 are in the same line as the described ones be-
fore for BS. The frequency obtained with the four tested
doses of PT were found in the same range as the deter-
mined ones in the negative control mice; nevertheless, a
statistically signiﬁcant MN increase was induced by dox-
orubicin. In relation to the PE rate, no change induced by
PT was observed in comparison with the control animals,
butasigniﬁcantdecreaseindoxorubicin-treatedmicewas
determined (Table 3).
DISCUSSION
Genotoxic studies are useful to identify the level of
DNA damage induced by xenobiotics, as well as to give
a clue about the possible clinical consequences of human
exposure. In vivo acute studies in mammalian organisms,
in particular, are usually considered the last type of assays
in a hierarchical test battery designed to determine the
genotoxic potential of an agent; in this step, high doses of
the tested compound are usually included; however, new
studies are needed to analyze risk assessment, that is, in-
corporating variables such as sex, age, time, dose, or route
ofadministration,tobetterunderstandthetoxicpotential
as well as to have more data for a reasonable extrapolation
to human exposure. In our study, the use of doses 20%
low than the LD50 obtained for the agents did not induce
an increase in the rate of SCE nor in the MNPE of mouse,
indicating no in vivo genotoxic potential of the chemicals
even at a high dose.
Micronuclei represent chromosome fragments or
whole chromosomes abnormally segregated to daughter
cells during mitosis, and although the SCE formation is
not clearly understood, it is usually related to DNA break
and rejoining at the replication fork [25, 26]. Thus, the
present study demonstrates that two diﬀerent cytogenetic
endpoints agree in their results giving more reliability to
a negative genotoxic potential of the tested compounds.
This is also important because the evaluated chromoso-
mal endpoints have been suggested as biomarkers for ma-
lignanttransformation[27,28],indicatingalowpotential
forthiskindofdamagebythechemicals.However,teststo246 R. Paniagua-P´ erez et al 2005:3 (2005)
Table 3. Eﬀect of beta-sitosterol (BS) and pteropodine (PT) in the index polychromatic erythrocytes/normochromatic erythrocytes
(PE/NE)inmousebloodcells.MO = mineral oil(0.4mLaddedtoeachmouse).DW = distilled water(0.4mLaddedtoeachmouse).
DR = doxorubicin.
Agent Dose PE/NE X ±SD
mg/kg 24h 48h 72h 96h
MO — 20.13 ±0.23 21.10 ±0.14 20.5 ±0.08 21.13 ±0.26
BS 200 19.8 ±0.46 18.8 ± 0.17 17.0 ±0.42 19.5 ±0.28
BS 400 20.3 ±0.43 19.7 ± 0.52 19.16 ±0.11 20.0 ±0.48
BS 600 20.0 ±0.19 19.5 ± 0.44 19.83 ±0.61 21.0 ±0.12
BS 1000 22.0 ±0.43 20.3 ± 0.19 20.14 ±0.05 21.3 ±0.57
DR 10 ∗9.1 ±0.37 ∗7.33 ±0.61 ∗5.33 ±0.33 ∗6.36 ±0.42
DW — 19.5 ±0.12 20.33 ±0.21 20.16 ±0.29 21.4 ±0.18
PT 100 16.33 ±0.38 19.66 ±0.18 20.6 ±0.19 21.8 ±0.49
PT 200 14.9 ±0.61 21.16 ±0.37 20.36 ±0.10 22.9 ±0.35
PT 300 16.51 ±0.32 21.5 ± 0.23 20.83 ±0.08 20.8 ±0.67
PT 600 17.62 ±0.29 22.0 ± 0.55 19.86 ±0.52 21.0 ±0.47
DR 10 ∗5.33 ±0.22 ∗8.1 ±0.16 ∗9.6 ±0.27 ∗8.06 ±0.39
∗Statistically signiﬁcant diﬀerence with respect to the result obtained in the negative control group. ANOVA and Student t tests, P ≤ .05.
measure genic damage, as well as chronic exposure to the
compounds,shouldbeperformedtohaveabetterconclu-
sion on the agent’s genotoxicity.
Our results concerning the absence of genotoxicity
by the tested agents are in line with the in vitro stud-
ies made in other sterols where low or no genetic alter-
ationshavebeenreported;althoughcytotoxicityindicated
by increased apoptosis and decrease in cell viability have
been observed, probably because of the inhibition of 3-
hydroxy-3-methyl-glutaryl-coenzyme A by the produc-
tion of free radicals [29]. With respect to PT and other
oxindoles, a weak cytotoxic eﬀect have also been observed
[14].Thesedata,determinedinculturedcells,conﬁrmthe
importance of studying the eﬀect of mutagens in in vivo
models because of the inﬂuence of biotransformation and
detoxiﬁcation processes.
The negative data obtained in the present study on
the genotoxic and cytotoxic potential of the tested com-
pounds encourage, with more certainty, the development
of research with the following aim: to determine the
pharmacological and chemopreventive activity of BS and
PT, as well as that of plants carrying them, leading to a
possible extrapolation to humans. In the antigenotoxicity
area in particular, our laboratory has observed a high in-
hibitory eﬀect of both chemicals on the SCE and MN
damage induced by doxorubicin in mouse (data are not
shown), a result that agrees with the few reports made
for BS on the matter, and with its antioxidant eﬀect [30].
With respect to PT however, no previous data for this ac-
tivity are known.
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